Try GOLD - Free

Intas Pharma bags another overseas co

Mint Mumbai

|

January 08, 2025

Gujarat-based drug-maker Intas Pharmaceuticals Ltd, which counts private equity firm ChrysCapital, Singapore state investment firm Temasek and Abu Dhabi Investment Authority (ADIA) as its investors, has signed a deal to acquire a biologic medication brand from US-based Coherus Biosciences.

- Sreeja Biswas

Intas Pharma bags another overseas co

Intas Pharma has agreed to buy Udenyca brand through its US specialty division, Accord BioPharma, for up to $558.4 million (nearly ₹4,800 crore), according to a press release.

Udenyca is the brand name for medication pegfilgrastim-cbqv, a bone marrow stimulant used to treat low white blood-cell counts in patients who take cancer medications.

MORE STORIES FROM Mint Mumbai

Mint Mumbai

Mint Mumbai

NBFCs go easy on MSMEs as bad loans begin to bite

Top NBFCs turn cautious as weakness in MSME sector reflects in repayments

time to read

4 mins

November 18, 2025

Mint Mumbai

Mint Mumbai

India's music stardom has moved from film sets to feeds

A few verses, a guitar, and an Instagram Reel were enough to catapult Anumita Nadesan into the national spotlight.

time to read

2 mins

November 18, 2025

Mint Mumbai

Mint Mumbai

NBFCs go easy on MSMEs as NPAs bite

IFL Finance maintains a \"very cautious status\" on MSMEs and the microfinance business, chief financial officer Kapish Jain told analysts on 31 October, adding the focus is largely on \"recovery and collection.”

time to read

2 mins

November 18, 2025

Mint Mumbai

Navi Mumbai to see flights from 25 Dec

Navi Mumbai International Airport (NMIA) will start commercial flight operations from 25 December and initially, there will be 23 scheduled daily departures.

time to read

1 min

November 18, 2025

Mint Mumbai

Trump's bets on China and Argentina are souring fast

When it comes to US foreign economic polic policy, President Donald Trump’s administration has two problems on its hands.

time to read

3 mins

November 18, 2025

Mint Mumbai

Inox Green loses grid access for 300 MW wind project

Clean energy developer Inox Green Energy Services has lost grid connectivity for its 300 megawatt (MW) wind project in Gujarat after failing to complete it on time, a filing with the power regulator showed.

time to read

1 min

November 18, 2025

Mint Mumbai

India-made 40nm chip to power smart meters by June

Cyient Ltd will start supplying a locally patented 40-nanometre (nm) chip to clients building smart electricity meters by June, according to the two top executives.

time to read

2 mins

November 18, 2025

Mint Mumbai

Gas for goodwill

Even as India’s exports to the US fell in October, as revealed by trade data issued by the government on Monday, Union petroleum and natural gas minister Hardeep Singh Puri announced the signing of a one-year agreement for the import of 2.2 million tonnes of liquefied petroleum gas (LPG) from America.

time to read

1 min

November 18, 2025

Mint Mumbai

Mint Mumbai

Rural demand drives FMCG growth in September quarter

India’s fast-moving consumer goods (FMCG) sector reported a 5.4% rise in September-quarter volumes, which moderated sequentially on account of disruptions related to the transition to new goods and services tax rates, while the value of sales jumped 12.9%, according to data released by consumer intelligence platform NielsenIQ.

time to read

1 mins

November 18, 2025

Mint Mumbai

Mint Mumbai

Advent, Warburg join Encube race; promoters may sell stake

Global private equity firms Advent International and Warburg Pincus have joined the race for a stake purchase in contract drug maker Encube Ethicals Pvt.Ltd, three people aware of the development said.

time to read

2 mins

November 18, 2025

Listen

Translate

Share

-
+

Change font size